Oxidative stress in chronic obstructive pulmonary disease patients submitted to a rehabilitation program

Respiratory Medicine

Volumn 101, Issue 8, 2007, Pages 1830-1835

  Pinho, R A ^a,c   Chiesa, D ^b   Mezzomo, K M ^b   Andrades, M E ^a   Bonatto, F ^a   Gelain, D ^a   Dal Pizzol, F ^a,c   Knorst, M M ^b   Moreira, J C F ^a  

^a Instituto de Ciencias Biologicas e da Saude Pontifical Catholic University of Minas Gerais   (Brazil)

^b HCPA   (Brazil)

^c UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

COPD; Oxidative stress; Physical exercise; Pulmonary rehabilitation

Indexed keywords

FREE RADICAL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; XANTHINE OXIDASE;

ADULT; AGED; ARTICLE; BICYCLE ERGOMETRY; BLOOD SAMPLING; CARDIOPULMONARY EXERCISE TEST; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE MARKER; ENDURANCE; ENZYME ACTIVITY; FORCED EXPIRATORY VOLUME; HEALTH PROGRAM; HUMAN; LIPID PEROXIDATION; LONG TERM CARE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; SITTING; TREATMENT DURATION;

BREATH TESTS; EXERCISE THERAPY; HUMANS; MIDDLE AGED; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS;

EID: 34250165825     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.02.004     Document Type: Article

References (26)

1. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., and Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 163 (2001) 1256-1276
2. Gerritsen W.B.M., Asin J., Zanen P., Bosch J.M.M., and Haas F.J.L.M. Markers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients. Respir Med 99 (2005) 84-90
3. Spencer H. Pathology of the lung. 5th ed (1996), McGraw-Hill, Philadelphia
4. Celli B., Goldstein R., Jardim J., and Knobil K. Future perspectives in COPD. Respir Med 99 (2005) S1-S48
5. Crapo R.O., Casaburi R., Coates A.L., et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors. Am J Respir Crit Care Med 161 (2000) 309-329
6. Mercken E.M., Hageman G.J., Schols A.M.W.J., Akkermans M.A., Bast A., and Wouters E.F.M. Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 172 (2005) 994-1001
7. Stevenson C.S., Koch L.G., and Britton S.L. Aerobic capacity, oxidant stress, and chronic obstructive pulmonary disease: a new take on an old hypothesis. Pharmacol Therap 110 (2006) 71-82
8. Liu J., Yeo H.C., Overvik-Douki E., Hagen T., Doniger S.J., Chyu D.W., et al. Chronically and acutely exercised rats: biomarkers of oxidative stress and endogenous antioxidants. J Appl Physiol 89 (2000) 21-28
9. Polidori M.C., Mecocci P., Cherubini A., and Senin U. Physical activity and oxidative stress during aging. Inter J Sports Med 21 (2000) 154-157
10. Quanjer P.H., Tammeling G.J., Cotes J.E., Pedersen O.F., Peslin R., and Yernault J.C. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European Community for steel and coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 16 (1993) 5-40
11. Tsal K., Hsu T.-G., Kong C.W., Lin K.C., and Lu F.G. Is the endogenous peroxyl-radical scavenging capacity of plasma protective in systemic inflammatory disorders in humans?. Free Radic Biol Med 28 (2000) 926-933
12. Draper H.H., and Hadley M. Malondialdehyde determination as index of lipid peroxidation. Meth Enzymol 186 (1990) 421-431
13. Beckman J.S., Parks D.A., Marshall P.A., and Freeman B.A. A sensitive fluorometric assay for measuring xanthine dehydrogenase and oxidase in tissues. Free Rad Biol Med 6 (1989) 607-615
14. Lowry O.H., Rosebough N.G., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
15. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
16. Repine I.E., Bast A., and Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. The oxidative stress study group. Am J Respir Crit Care Med 156 (1997) 341-357
17. MacNee W., and Rahman I. Is oxidative stress central the pathogenisis of chronic obstructive pulmonary disease?. TRENDS Mol Med 7 (2001) 55-62
18. Zhang Z., Shen H.-M., Zhang Q.-F., and Ong C.-N. Critical role of GSH in silica-induced oxidative stress, cytotoxicity, and genotoxicity in macrophages. Am J Physiol 277 (1999) L743-L748
19. Rahman I., and MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 16 (2000) 534-554
20. 2 therapy. J Appl Physiol 81 (1996) 2199-2202
21. Heunks L.M.A., and Dekhuijzen P.N.R. Respiratory muscle function and free radicals: from cell to COPD. Thorax 55 (2000) 704-716
22. Agacdiken A., Basyigit I., Ozden M., et al. The effects of antioxidants on exercise-induced lipid peroxidation in patients with COPD. Respirology 9 (2004) 38-42
23. Pratico D., Basili S., Vieri M., Cordova C., Violi F., and Fitzgerald G.A. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. Am J Respir Crit Care Med 158 (1998) 1709-1714
24. Paredi P., Kharitonov S.A., Leak D., Ward S., Cramer D., and Barnes P.J. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162 (2000) 369-373
25. König D., and Berg A. Exercise and oxidative stress: is there a need for additional antioxidants. Österreichisches J Für Sportmedizin 3 (2002) 6-15
26. Heunks L.M., Vina J., van Herwaarden C.L., Folgering H.T., Gimeno A., and Dekhuijzen P.N. Xanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am Physiol Soc 277 (1999) 1697-1704